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In order for human microbiome studies to translate into actionable outcomes for health, meta-analysis of reproducible data from population-scale cohorts is needed. Achieving sufficient reproducibility in microbiome research has proven challenging. We report a baseline investigation of variability in taxonomic profiling for the Microbiome Quality Control (MBQC) project baseline study (MBQC-base). Blinded specimen sets from human stool, chemostats, and artificial microbial communities were sequenced by 15 laboratories and analyzed using nine bioinformatics protocols. Variability depended most on biospecimen type and origin, followed by DNA extraction, sample handling environment, and bioinformatics. Analysis of artificial community specimens revealed differences in extraction efficiency and bioinformatic classification. These results may guide researchers in experimental design choices for gut microbiome studies.
Translation of basic microbiome research to population studies and the clinic requires reproducible experimental and computational methods for analyzing human-associated microbial communities. The Human Microbiome Project (HMP) 1 , MetaHIT 2 , and other large consortia [3] [4] [5] have produced protocols that can be used to characterize human microbiomes, but relatively few epidemiological studies have evaluated the role of the human microbiota in health with the degree of standardization necessary for translational applications. Inter-study technical variability in microbiome measurements can sometimes, for example, outweigh biological effects [6] [7] [8] [9] . Basic scientists, clinicians, epidemiologists, microbiologists, statisticians, and bioinformaticians should thus collaborate to develop best practices and to identify potential measurement variability in each step of microbial profiling.
Inspired by studies such as the Microarray Quality Control (MAQC) and Sequencing Quality Control (SEQC) projects 10 , we initiated the Microbiome Quality Control (MBQC) project to address this need. The MBQC aims to evaluate methods for measuring the human microbiome, including protocols for handling human microbiome samples and computational pipelines for microbial data processing. The goal of the MBQC is not to define the 'best' protocols for human microbiome studies. Instead, the aim is to inform experimental design by identifying the relative effect sizes of individual variables and to provide a menu of context-dependent protocol choices. This will enable the community to quantify the inter-study variation of protocol variables, provide a set of context-dependent protocol choices, help develop guidelines for minimum reporting standards, develop methods for normalization and systematic meta-analysis, facilitate consensus on best practice in epidemiological and translational human microbiome studies, and promote open sharing of standard operating procedures. We expand on many previous studies that have evaluated aspects of microbiome data generation protocols, although typically neither in the context of population epidemiology nor across multiple laboratories [11] [12] [13] [14] (Table 1 ; full list in Supplementary Data set 1; Supplementary Note 1).
We report the baseline (MBQC-base) results, in which we evaluate the variability in taxonomic profiling of the gut microbiome introduced during amplicon data generation. Specifically, the steps evaluated included experimental sample handling (DNA extraction 15 , 16S rRNA gene amplification 16 , and sequencing) and bioinformatic data processing. This baseline MBQC was carried out by volunteer laboratories; all samples were provided by a central repository, blinded, and handled by 15 laboratories. Re-blinded data were analyzed by nine bioinformatics laboratories, to produce more than 16,000 taxonomic profiles (approximately three times the size of the HMP 17 ). The MBQC analyzed the detailed protocols carried out by handling and bioinformatic laboratories to identify factors that contribute to variability.
Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium
Specimen selection, set design, and blinding To facilitate assessment of variation among handling laboratories introduced during DNA extraction, staff at a central facility extracted aliquots of the 22 specimens using the MO-BIO PowerSoil kit. The resulting combination of specimens and extracted DNA comprised 96 aliquots with 60% duplicates and 40% triplicates. The final aliquot set included 41 aliquots of centrally extracted DNA, 53 aliquots of raw specimens (frozen and freeze-dried feces, chemostat, and Publications in this table were required to compare multiple protocols, target whole communities (not single  microbial genomes) , and to be neither phylogenetically targeted (i.e., as bacterially universal as possible) nor specific to 454 pyrosequencing (although comparisons to such data were included). In addition to computational analyses, we subdivide the sample handling/data generation process here into approximate stages: positive controls in the form of one or more mock communities; sample collection and storage or fixation; nucleotide extraction; PCR primer or variable region selection; other aspects of PCR amplification (e.g., enzyme, cycles, index design); sequencing platform; and negative controls or contaminant analysis. Variables broadly tested in each study are marked with "+" if a significant finding was reported or "−" if the variable's effects were non-significant or described as low effect size (non-tested variables are unmarked). Mock community codes indicate "+" if a positive control was included but sequencing results diverged substantially from the expected reference, "−" if sequencing results for all included positive controls agreed with the expected gold standard.
artificial communities), and two negative-control aliquots of storage buffer (Supplementary Table 2 ). Each handling laboratory received one or more of these 96-aliquot sets. The number of unique specimens, raw versus extracted aliquots, and replicates or triplicates was chosen to maximize power in quantifying variance introduced by protocol choice in DNA extraction, sequencing, and bioinformatics, as well as that from intrinsic sample characteristics such as subject and specimen type. Briefly, data from balanced, triplicate-or replicate-enriched designs were simulated using different proportions of raw versus extracted aliquots. Fixed (to estimate effect size) and random effects (to estimate variance) models were fit and their accuracy assessed by the sum of squared deviation over all effects and data sets. Near-balanced replicates and triplicates (54 vs. 42 aliquots, respectively) and raw aliquots (53 raw vs. 43 pre-extracted) were the best-powered in our simulations and hence yielded the final aliquot set design. All aliquots in the set were assigned blinded identifiers before distribution, such that handling laboratories received no information linking aliquots either to replicates or to specimens of origin.
Sample handling and bioinformatics protocols From these aliquots, handling laboratories generated a total of ~215 M sequence reads spanning 2,250 samples (aliquot-laboratory combinations, Supplementary Data set 5). Handling protocols included nine different extraction kits (predominantly MO-BIO, Carlsbad, CA), and most incorporated a bead-beating homogenization step ( Table 2 and Supplementary Data sets 2 and 3 and http://mbqc.org for detailed protocols). All handling laboratories except one used V4 primers from one of two protocols 19, 20 ; one laboratory used a V3-4 primer pair 21 . One laboratory used Illumina HiSeq, all the others used MiSeq, and almost all protocols (13) used paired-end overlapping reads. Finally, one laboratory deposited data after data sets were redistributed, yielding a total of 14 handling laboratories' data, which were distributed for bioinformatic analyses (all raw data are available at the DACC).
Each sample-handling laboratory deposited demultiplexed FASTQ files containing the resulting data at the DACC, which were then reblinded for distribution to bioinformatics participants. Bioinformatics protocols ( Table 2 ; please see Supplementary Data sets 2 and 3 and http://mbqc.org for detailed protocols), broadly included steps for read filtering and quality control (QC), overlapped read stitching, OTU calling, and OTU table QC. Read QC, when performed, generally comprised removal of low-quality bases and, subsequently, reads below a length threshold. Read stitching (or assembly) merged mates from paired-end samples, discarding reads that failed to meet mismatch or base quality thresholds. OTU QC most often included feature or row QC, that is, removal of OTUs below an abundance or prevalence threshold; some laboratories also performed sample or column QC to omit samples with too few reads (Supplementary Note 2).
Taxonomic profiles
The combination of read-level QC and OTU assignment yielded an average of ~40 M reads per sample handling laboratory and ~35,000 ± 43,700 reads/sample, for a total of 15,749 filtered samples (each sample being a unique combination of aliquot, handling laboratory, and bioinformatics laboratory; Supplementary Table 4). These comprised 11,991 human-derived samples, 2,033 control artificial communities, and 1,725 chemostat-derived samples used for subsequent analysis; all combined OTU analyses excluded two laboratories that provided only open-reference OTU calls without mergeable Greengenes identifiers (BL-5 and BL-7). After quality control, most bioinformatics laboratories generated sequence data sets with highly negatively skewed distributions, that is, low-count outlier samples were discarded, and high-count samples retained. The two laboratories using fully openreference OTU calling found high variance in their per-sample QC criteria, because in some, but not all, samples many reads were captured only by de novo OTUs.
Reads and QC together produced 27,211 OTUs with Greengenes v13.5 identifiers that are detailed in the summary MBQC-base A n A ly s i s samples processed during the MBQC-base using blinded samples; an additional mothur-based protocol was added post hoc. This produced comparable taxonomic profiles to MBQC-base bioinformatics, shifted significantly (but with modest effect size) to deplete some clades that were dominant in protocols from bioinformatics labs 1-9 (BL-1 to BL-9; e.g., genus Fusobacterium, unclassified Enterobacteriaceae, most species-level assignments) and enriching the otherwise less-abundant Firmicutes (Paenibacillus, Blautia, Phascolarctobacterium, Oscillospira, and other genera; Supplementary Fig. 1) .
A qualitative overview of sample beta-diversity values (Fig. 2 ) revealed that biological, experimental, and bioinformatics variables all contribute to facets of between-sample variation ( Supplementary  Fig. 1 ). Most human-and chemostat-derived samples cluster together, with the biologically distinct artificial communities and a subset of human-derived samples forming outgroups. Differences induced by a subset of computational protocols are readily visible (e.g., BL-8), with those arising from sample handling protocol choices more difficult to see in this visualization but nevertheless present (e.g., handling lab (HL)-D or HL-E; see Fig. 3 ). Interestingly, human-and chemostat-derived samples do not segregate substantially in this high-level overview, highlighting the latter's value as biologically realistic positive controls.
Variation in taxonomic profiles
To quantify the effects of protocol differences on microbial community composition ( Supplementary Fig. 1 and Supplementary Note 3), we evaluated within-and between-sample diversity for bioinformatics, sample handling, and DNA extraction protocol variation (separating each basic specimen type; Fig. 3 and Supplementary Table 6 ). Quantitative alpha diversity was relatively robust to protocol differences ( Fig. 3a) , although both bioinformatics and sample handling protocols tended to affect the median observed diversity more than biological specimen type. Absolute levels of diversity varied among laboratories ( Supplementary Figs. 2 and 3) , although relative correlations between community profiles in the 22 primary specimens across laboratories remained high (min. Spearman r = 0.9; Supplementary Note 4).
For each specimen, beta diversity distributions summarize the difference between replicate samples within one variable, for example, dry laboratory, wet laboratory, or extraction kit, and all other values in the variable set (Fig. 3b) . For example, when comparing bioinformatics laboratories, each boxplot summarizes the set of beta diversities between each specimen's replicate samples as analyzed by one laboratory and the same specimen's replicates as analyzed by all other laboratories. Comparisons were also stratified by sample type (human-derived, chemostat, or artificial community). While handling by each bioinformatics laboratory induced a modest overall shift in samples′ microbial profiles, handling by only one laboratory (BL-8) resulted in a consistent, large shift in the sample composition. Differences owing to sample handling in laboratories were generally larger than the effect size of sample type, especially in those laboratories that handled samples extracted centrally and in other locations (e.g., HL-E processed DNA samples extracted by the HL-F, HL-J, and HL-A laboratories). Grossly different beta-diversity profiles were generally caused by a subset of samples that were strikingly dissimilar, rather than consistent differences in all of the samples, indicating that a handful of samples may have been contaminated, mislabeled, or otherwise altered in these laboratories.
We observed that any protocol variable can produce large technical differences, as evidenced by a small number of outlying, large effect size contrasts in all of the extraction, sequencing, and bioinformatics comparisons (Fig. 3c) . However, in almost all cases, the range of differences between samples was greatest for the 18 human-derived specimens. This means that the overall effect size of biological variation outweighed that of computational or experimental protocol choices ( Supplementary Fig. 4 and Supplementary Table 7) .
Variation among biospecimens
We found that different types of specimen were differentially affected by laboratory protocol choices (Supplementary Fig. 5 ). Some samples, for example, artificial communities, were minimally affected by different sample handling protocols, and there was no statistically significant variation in measures of diversity (e.g., Simpson's diversity) associated with a handling laboratory. For all other samples, however, there was up to fivefold variation between communities profiled in different laboratories This agrees with our observation that relative diversity levels remain consistent (Supplementary Figs. 2 and 4), because each protocol will have a set of biases that affect all samples equally. To summarize, estimates of absolute diversity are not comparable among laboratories even when processed using the same bioinformatics pipeline, whereas relative diversity levels are on average consistent among similar sample types. Sample-specific effects on diversity occurred due to bioinformatics protocol choices as well. There was no single bioinformatics pipeline that was consistently either the least or most conservative in estimating the effects of the handling laboratory on measures of community structure such as alpha diversity (Supplementary Fig. 6 ). This resulted in complex interactions between handling and bioinformatics protocol choices: some sample diversity estimates agreed across handling laboratories and bioinformatics protocols, while others differed significantly across handling, bioinformatics, or both ( Supplementary   Fig. 7 ). While some of these interactions might arise from technical sources such as sample mislabeling, our results suggest that microbial physiology, nucleotide composition, protocol biochemistry, and computational assumptions can all interact to induce variation in microbiome assay results 9 .
More broadly, our findings suggest that standardization efforts themselves need to be scaled up, because our data show that experiments on only one or a few samples can produce results that are not fully generalizable among distinct experiments or populations.
Variation due to extraction protocol DNA extraction protocols are a known source of variation between microbial community characterization experiments [7] [8] [9] . We separated variation caused by DNA extraction from variation owing to PCR and sequencing by comparing centrally versus locally extracted samples (Supplementary Fig. 8 ). 22 unique specimens had replicate aliquots sequenced from DNA that was extracted either by individual handling laboratories (locally) or centrally using a single MO-BIO-based protocol. Beta diversities between locally versus centrally extracted samples were specimen-specific, with some samples D2497  D2561  D2590  D2696  D2698  DZ15291  DZ15292  DZ15293  DZ15294  DZ15295  DZ15296  DZ15298  DZ15300  DZ15302  DZ15303 16 ,554 samples corresponding to 2,237 replicated sequencing results on 22 originating physical specimens (human-derived, chemostat, and oral and gut artificial communities) using multidimensional scaling of Bray-Curtis dissimilarities. Labels indicate stratification by sample handling laboratory (a), specimen type (b), bioinformatics laboratory (c), or subject (d). Major contributors to between-sample diversity thus include biological origin, handling protocol differences, and bioinformatics protocol variables ( Supplementary Fig. 1 ).
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showing little effect and others differing substantially, primarily based on this single handling protocol variable (Supplementary Note 5 and Supplementary Fig. 9 ).
Positive controls
We included positive-(artificial community) and negative-(buffer blank) control samples so that we could assess the overall accuracy of different protocols (Fig. 4) . Specifically, each sample set included two artificial communities, one comprising 20 gut microbiota species and one comprising 22 oral species (Supplementary Table 1 ). These were blinded and processed alongside fecal and chemostat specimens during data generation and processing. Sample handling and bioinformatics protocols had an effect on community profile accuracy (Fig. 4a,b) , but the largest contributor to variability was contamination or omissions because the DNA of some microbes was not extracted (Supplementary Fig. 10 ). Bioinformatics protocol differences had less impact (Fig. 4a,b) .
Nearly every combination of extraction, sequencing and bioinformatics protocols affected artificial community taxonomic profiles in at least one sample (Supplementary Fig. 10 ). Fecal and oral microbes were depleted in all bioinformatics protocols in the handling laboratory using V3-4 primers (HL-A), in favor of genus Lactobacillus. However, laboratory-specific effects also interacted with the bioinformatics protocols. Fusobacterium was only substantively detected in HL-A samples by the BL-2 and BL-6 pipelines, for example, or by BL-1, BL-4, and BL-9A in the sole HiSeq laboratory, HL-L. Some handling laboratories introduced different biases in locally versus centrally extracted samples (e.g., HL-E), which then produced different profiles in bioinformatics laboratories owing to the systematic differences in input sequences. Overall taxonomic profiles were also sensitive to handling protocol, bioinformatics, and to the interaction of these variables, although all estimates of OTU richness were high (means ~30-35 for centrally and locally extracted samples, respectively) and neared 100 OTUs in one case (HL-E handling, BL-6 bioinformatics), despite an expectation of 20 and 22 (fecal and oral, respectively) and low rarefaction depth of 1,000 sequences (Supplementary Fig. 11 ).
To check artificial community composition, six gut and six oral artificial community samples were centrally subjected to metagenomic sequencing (half pre-and half re-extracted), profiled with MetaPhlAn2 BL-6 BL-9A BL-1 Figure 3 Individual and aggregate effects of sample handling and bioinformatics laboratories on microbial profiles. (a,b) Distributions of within-and between-sample alpha and beta diversities, respectively, stratified by sample type (n = 2,033 for artificial communities, n = 11,991 for humanderived samples, and n = 1,725 for chemostat samples) and by handling (a) or bioinformatics laboratory (b). Raw data, including sample sizes, are included in Supplementary Data set 7. Bray-Curtis dissimilarities within laboratories are computed only between technical replicates handled and extracted identically; between-laboratory distributions compare only replicates from the same originating specimen as processed by one laboratory to all others. Outlier values outside 1.5 times the interquartile range are omitted for clarity. Within-laboratory comparisons thus assess the consistency of each laboratory between replicates; between-laboratory comparisons assess how (dis)similar each laboratory's results are to all others. (c) Effect size distributions of technical variation (between identically handled replicate samples), including, from bottom to top, differences due only to bioinformatics laboratory, sequencing laboratory, extraction (local vs. central), and between different biological specimens. In general, biological differences were largest, followed by extraction (particularly for heterogeneous human-derived samples), sequencing protocol, and computational protocol effects were smallest. Omnibus tests for differences among specimen type, handling laboratory, and bioinformatics laboratory are all significant at Kruskal-Wallis P < 0.05; pairwise Wilcoxon tests for the effects of most individual handling laboratories are significant, while those of most bioinformatics laboratories are not (Supplementary Table 6 ).
(ref. 22) , and compared with 16S amplicon-derived abundances ( Fig. 4c and Supplementary Fig. 12) . Although factors such as PCR, re-extraction, and database representation (16S versus whole genome) all prevent perfect correlations between amplicon and metagenomic data, this experiment supported the expected ground truth and further confirmed the variability of laboratory and bioinformatics protocols when reading out even these low-complexity communities.
Finally, raw reads deposited by each handling laboratory, before any bioinformatics, were analyzed to assess the potential causes of artifacts (Supplementary Fig. 13 ). Approximately 50-80% of 16S amplicon reads matched one of the 20 or 22 fecal/oral reference sequences exactly, with most laboratories varying only slightly (typically <10%) between samples. Single base error accounted for many of the remainder, at a rate of 0.15-0.2% per nucleotide, while two laboratories (HL-C and HL-N, two of only three laboratories using single-indexed 8-nt barcodes) also generated 1-3% mismatched sequences due to single base gaps at the barcode or linker. Chimeric reads represented another ~1-5% of mismatched reads across all laboratories, although this rate did not vary monotonically with number of PCR thermal cycles (Supplementary Data set 2 ). Interestingly, read-level error rates did not correlate with handling laboratories' diversity averages. Instead, inflated diversity arose from other handling (e.g., contamination) or bioinformatics sources, although such errors do decrease absolute accuracy in taxonomic profile assessment (Fig. 4) .
A substantial source of errant sequences in the positive-control samples (and, below, in negative controls as well) proved to be reads originating from other samples or, possibly, from external contaminants (Supplementary Fig. 14) . Artificial community samples from all laboratories included substantial reads identical to those most abundant in other MBQC specimens. Three laboratories that used single 8-nt barcodes (HL-C, HL-N, and HL-I) had the highest proportion of these reads, although this factor was not directly associated with diversity rates (Supplementary Fig. 11 ) or absolute accuracy (Fig. 4) . A per-barcode synthesis error rate comparable to the per-read errors above (~0.2%) is sufficient to explain much of this effect, leading to a non-negligible fraction of reads being assigned to the wrong sample through barcode hopping ("bar-hopping"). While the MBQC-base sample size is too small to quantify the relative sizes of these effects, sequencing error, extraction efficiency, computational stringency, bar-hopping, and contamination may all have detectable and combinatorial roles in taxonomic profiling errors.
Negative controls
We included Tris-HCl buffer aliquots as negative control samples (two per 96-sample set) (Fig. 4d) . In total, 345 negative controls were fully processed. At least one OTU was reported in 342 of these samples, with the observed number ranging from 1 to ~130 at low (1,000 sequences) rarefaction and almost 200 in all sequences ( Supplementary  Fig. 11 ). Sources of contamination varied, including one laboratory with samples comprising mainly Lactobacillus (HL-A), three laboratories with Pseudomonas (possibly reagent contamination 23 , HL-B, HL-F, and HL-D), and sequence, bioinformatic, and/or physical contamination from gut-derived samples in all laboratories. The most abundant contaminant OTU was an unidentified Bacteroides at 1.6 s.d. 7.0%, which was detected in 22.6% of negative-control samples and was also abundant in stool samples (average 1.2 s.d. 3.7%). Of the top 100 most-abundant false-positive Greengenes identifiers (average relative abundances ranging from 0.2% to 1.5%), 34% were from genera Bacteroides; Fecalibacterium prausnitzii also comprised 9% of the (averaging each over all sample handlers). Error bars show standard error; no data were provided by combinations that are missing bars. Raw data, including sample sizes, are included in Supplementary Data set 8. Sample handling had a greater overall effect on distance from truth, and showed greater variation, than did bioinformatics; some effects were specific only to locally or centrally extracted samples and appeared to be driven by contamination of only these respective sample subsets ( Supplementary Figs. 9 and 10). (c) Spearman correlation between whole metagenome shotgun (WMS) and 16S amplicon sequence data on centrally and locally extracted gut-derived artificial communities. Points indicate each of 17 species that were jointly identifiable in both data types, due to uniquely identifiable species-level agreement between the Greengenes and MetaPhlAn taxonomies ( Supplementary Fig. 12 ). A n A ly s i s top 100 IDs, genus Pseudomonas 7%, and family Enterobacteriaceae 6% (Supplementary Note 6).
Multivariate quantification of variation
As a final, joint quantification of the multiple aspects of variance among both sample handling and bioinformatics protocols, we fit two mixed effects models to the transformed abundances of the four major gut phyla (Actinobacteria, Bacteroides, Firmicutes, and Proteobacteria; Supplementary Table 8, Supplementary Fig. 15 and Fig. 5 ). Using arcsine-square root transformed phylum-level taxonomic abundances as a readout, the greatest variability in microbiome profiling was assigned to biological differences between specimen sources and handling laboratories, as in the univariate whole-community models above. Additionally, DNA extraction method was the individual protocol variable of greatest effect, also as observed in univariate analyses. Centrally extracted (pre-extracted) samples were associated with higher abundances of Bacteroidetes; since all pre-extracted samples were extracted using a MO-BIO kit, these results are consistent with reports showing that the MO-BIO-based HMP protocol generated data enriched for genera within the Bacteroidetes 24 . Finally, our full model was unable to assign significance to any specific fixed effects (i.e., individual protocol variables), since in the small MBQC-base these were in large part confounded with individual handling and bioinformatics laboratories (Supplementary Fig. 15 ). Because this leaves a large proportion of taxonomic variation unaccounted for, systematic assessment of individual protocol variables (e.g., individual extraction kits, amplification primers, or sequence filtering parameters) will be crucial for the next phase of the MBQC.
DISCUSSION
We report the baseline study from the MBQC project consortium. This project has been set up to improve reproducibility and rigor of microbiome analyses, so that human microbiome studies can be used for population epidemiology and translation into therapeutics 9, 25 . We found that each microbiome protocol step, including sample handling environment, DNA extraction, and bioinformatic processing has the potential to introduce variation of comparable effect size to that of biological differences. Within these broad categories, almost any data generation or analysis protocol choice has the potential to yield divergent results. This is visible, for example, in the long tails of outliers in Figure 3 , and in the finding that almost half of the participating wet laboratories produced variable results for positive-control artificial communities. Conversely, however, many potential sources of variation (sequencing platform, chemistry, sequence-level bioinformatics, and others) were, when detectable, typically of smaller effect size than phenotypes of clinical interest. The goal of the MBQC project is to provide information that will allow microbiome researchers and regulators to make informed design choices, rather than to prescribe specific protocols (Supplementary  Note 7) . Our results indicate that carrying out meta-analyses of microbiome studies is challenging at present because individual experiments frequently include incompatible protocol variables. Of note, there are no batch normalization approaches for microbiome data, unlike in transcriptional or genetic meta-analyses 26 . Previous detailed investigations of specific variables in microbiome experiments, such as DNA extraction methods, have, in common with the results we report, enriched for broad classes of Gram-negative rather than Gram-positive bacteria owing to technical rather than biological variables 9, 24, 27, 28 . Likewise, choices of 16S rRNA gene variableregion primers may enable improved detection or differentiation of microbes 16 ; for example, Propionibacterium spp. though abundant on the skin are often undetected by V4 primers 29 , and Lactobacillus spp. in the vagina are better differentiated by including V3 (ref. 21) . Furthermore, different human host cohorts may harbor remarkably different Gram-negative versus Gram-positive diversity 3, 30 , and a protocol appropriate for one type of community may work well in one study but not in another. Some bioinformatics protocol choices can mitigate these differences; for example, relative (rather than absolute) diversity measures, phylogenetic (rather than taxonomic) analyses, and quantitative (rather than based on presence or absence) measures all tended to be more robust to inter-protocol variation.
In our view, the wide variation in biological questions, coupled with technical variability, precludes the recommendation of a single best protocol for all studies, although standards should be agreed upon that capture a consensus of compatible protocol choices and document their applicability in large-scale epidemiological studies. Sequencing data for positive controls diverge in almost every published study 28 , including ours (Supplementary Data set 1) , which confirms that relative, not absolute, measures are comparable between protocols. Likewise, many studies, including ours, agree that DNA extraction (particularly bead beating), 16S rRNA gene primer selection, and negative-control contamination have large effects on variation. Previous results have been mixed in their characterization of sequencing platform effects; we included Illumina MiSeq and HiSeq 16S data, but earlier evaluations capture these, Roche 454, Ion Torrent, Pacific Biosciences, and other technologies (including comparisons of amplicon and shotgun metagenomic sequencing). Almost all cases in which platforms differed [31] [32] [33] specifically investigated Ion Torrent 16S amplicon sequencing (Supplementary Note 8) .
In the next phase of the MBQC project, we expect to carry out systematic surveys of microbiome assay protocols (Supplementary  Note 9) . Among other variables of interest, the community will need a shared library of positive-control standards for different microbial *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** Table 8 and Supplementary  Fig. 15 ). Variability in taxonomic profiling is dominated by systematic differences between handling laboratory protocols in addition to choice of DNA extraction kit, while bioinformatics protocol choices were much smaller at the phylum level. Bar length indicates the magnitude of average differences in abundance contributed by each laboratory (a) or variation contributed by different specimens or by noise (b). ***, P < 0.001. All parameters were tested using a likelihood ratio test with BenjaminiHochberg-Yekutieli FDR correction across all outcomes.
habitats, such as 'typical' gut, skin, oral, or other microbial mixtures of defined composition, as well as guidelines for including these in addition to negative controls for simultaneous within-and between-study standardization. The results we present here set the scene for the next phase of addressing variability in microbiome studies.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Biological specimens. Fresh specimens. Fresh stool samples were collected in a plastic commode (Fisherbrand Commode Specimen Collection System, Fisher 02-544-208), ziplock bag, diaper, or clinical urine collection container from volunteers under the IRB protocol 0409.13 at the University of Colorado, Boulder. These were frozen at −20 °C if immediate aliquoting was not possible, and any initially frozen samples were thawed at room temperature for aliquoting. Bulk fecal samples for DNA extraction were scooped into a sampling tube (Fecal Collection Containers, Globe Scientific -Polystyrene, VWR 60820-100) using a plastic spatula (Fisherbrand Disposable Sterile Spatula, Fisher 14-375-253), frozen, and sent to the Allen-Vercoe laboratory at the University of Guelph, Canada, on dry ice. To make fresh aliquots, 10 g of thawed fecal matter was added to a 250 ml disposable sterile bottle (Corning, Fisher 09-761-4) and combined with 85 ml of EB buffer (Qiagen 19086). Specimens were vortexed until the mixture was as homogenous as possible. One hundred µl of fresh stool samples were aliquoted into 1.2 ml cryovials (Fisher 12567500) at room temperature. The aliquots were stored overnight at −20 °C, and then transferred to −80 °C until they were shipped to the NCI repository, in Frederick Maryland, on dry ice for specimen set construction.
Freeze-dried specimens. Freeze-dried specimen collection procedures and donors have been outlined previously 52 . Briefly, newly diagnosed cases with adenocarcinoma of the colon or rectum were recruited before surgery and treatment during 1985-1989 (refs. 52,53) . Controls were patients awaiting elective surgery for non-oncologic, non-gastrointestinal conditions at these hospitals during the same period. A median of 6 days (IQR 3-13 days) before hospitalization and surgery, participants completed dietary and demographic questionnaires and provided 2-day fecal samples that were frozen at home on dry ice and subsequently lyophilized. Some of the participants provided an additional 2-day fecal sample 4 to 6 months later. The two-day lyophilates were pooled, mixed and stored at −40 °C. This study was reviewed and approved by an Institutional Review Board at the National Cancer Institute 52, 53 and approval from the the NCI Office of Human Subjects Research No. 11147. Fecal samples from three controls and four cases in the original study were included in the MBQC study.
Chemostat (robogut) specimens. A single-stage chemostat model of the human distal gut ecosystem was used to develop controlled fecal communities with realistic ecological diversity, as outlined previously 54 . One healthy donor (male, 25 years old) provided fresh fecal samples on two separate occasions, 3 months apart that were used to inoculate two separate chemostat runs. Briefly, fresh fecal samples were placed into a Concept 300 anaerobic chamber (Ruskinn, Sanford, ME) supporting an atmosphere of H 2 :CO 2 :N 2, 10:10:80, within 5-10 min of voiding. A 10% (w/v) fecal slurry was prepared by homogenizing 5 g of feces in 50 mL of pre-reduced growth medium for 1 min using a stomacher (Tekmar Stomacher Laboratory Blender, Seward; Worthing, West Sussex, UK). The resulting slurry was centrifuged for 10 min at 175g to remove large food particles 55 , and 100 mL of the supernatant slurry was added to 300 mL of sterile growth medium in each vessel. Cultures were gently agitated and vessel pH was adjusted to 6.9-7.0. Medium feed was started 24 h post-inoculation, and the culture was grown for 22 days before harvesting and aliquoting. The Research Ethics Board of the University of Guelph approved this study (REB10JL002).
Artificial (mock) communities. Artificial communities were developed from in-house isolates representative of the range of bacterial genera found within the oral or gut habitats, including both Gram-positive and Gram-negative bacteria with a range of genomic G+C ratios (Supplementary Table 1 ). All strains were originally isolated from human subjects, and HMP genome reference strains were included where available 56 . Each strain was separately cultured on Fastidious Anaerobe Agar (FAA) (Acumedia, Lansing, MI) supplemented with 5% defibrinated sheep's blood (Hemostat, Dixon, CA) for 72 h at 37 °C under anaerobic conditions in a Concept 300 anaerobe chamber as above, H 2 : CO 2 :N 2, 10:10:80, with the exception of 1_1_55 (K. pneumoniae), 30_1 (Ent. saccharolyticus), 1_1_43 (Esch. coli), and 5_7_47FAA (R. pickettii) that were grown on FAA under aerobic conditions (the latter with no blood supplementation and at 30 °C), and GT4ACT1 (N. mucosae) and CC94D (G. adiacens) that were grown on FAA under an atmosphere of 5% CO 2 . Biomass for each community was scraped from relevant plates using 10 µL inoculating loops (Globe Scientific Inc., Paramus, NJ) and transferred to 500 mL filter-sterilized saline (0.9% w/v NaCl) to a final OD 600nm of 0.191 for oral and 0.131 for gut community suspensions. Similar numbers of loops were inoculated for most species and inoculated cell densities were estimated as multiples of 7.5 × 10 10 (approximate CFU/mL of a 10 µL inoculating loop). Some species grew poorly and harvesting biomass was difficult; hence for these isolates (e.g., CD1 D5 FAA 3, M. timidum, and CD1 D5 FAA 6, D. pneumosintes), as much biomass as possible was included in the final suspension. Samples were aliquotted after gentle mixing to ensure an even suspension, and immediately frozen at −20 °C before shipping to the NCI repository, or prepared for DNA extraction.
Negative control blanks. Blank samples consisted of 10 mM Tris-HCl pH 8.5 (Qiagen 19086).
Sample sets. Upon registering, each of the 15 sample handling laboratories was sent a minimum of one set containing 96 samples in Fisher 1.2 mL Cryovial (Product Code 12567500) tubes on dry ice. Each set contained, first, non-extracted replicates (at least duplicate, some triplicate) totaling 25 fresh stool, 16 freeze-dried stool, 6 chemostat-derived, and 6 artificial community samples (Supplementary Table 2) . Each set further contained centrally extracted DNA: 17 from fresh stool, 14 from freeze-dried stool, 4 from chemostat, and 6 from the artificial communities. Finally, each sample set also included two negative-control blank samples. Frozen fresh stool were shipped frozen as described above, freeze-dried stool were shipped in 1 mL sterile Elution Buffer (Qiagen 19086), and extracted DNA was shipped in 10 µl aliquots of 10 mM Tris. The samples were placed in the same order for each laboratory. Participating laboratories were blinded to sample collection methods or sample types. All sample types, metadata, and phenotypes remained blinded to participants until consolidated data release at the end of the baseline experiment.
Sample sets were designed by simulation under the constraints that, of 96 total samples, 40-60% should be pre-extracted DNA (the remainder raw specimens), 40-60% should represent duplicates, and 40-60% triplicates. Specimens 3, 11, 13, and 14 were required to be represented at least once (as these represented potential outlier phenotypes from samples captured in the ICU), and simulations aimed to select as many different subjects as possible in addition to these. Of non-control specimens, 40-60% of samples were required to be fresh (not freeze-dried) stool, and 40-60% of samples were required to derive from healthy subject specimens. Finally, all control samples (chemostat, artificial, and negative) were required to be included, the positive controls (two chemostat and two artificial) as both pre-extracted and raw specimens. This parameter space was searched exhaustively in R and one of the several sample configurations that near equally maximized power to partition variance (as described below by multivariate modeling) was selected for construction and distribution.
DNA extraction. Central DNA extraction. The sample subset with centrally extracted DNA was generated at the University of Guelph using the PowerMax Soil DNA Isolation Kit (MoBio Laboratories Inc., Carlsbad, CA) according to manufacturer's instructions. A range of sample DNA concentrations and Abs 260/280 values were obtained, as measured using a NanoDrop ND-8000 instrument (Wilmington, DE) and are detailed in Supplementary Data set 2. DNA samples were aliquoted to cryotubes and frozen at −20 °C before shipping to the NCI repository.
Individual handling laboratories. Upon receipt of the samples, all laboratories froze the sample sets at −20 °C or −80 °C before DNA extraction (Supplementary Data set 2) . The samples remained frozen anywhere from 4 days to 92 days. Most laboratories thawed samples at room temperature, but a few laboratories thawed the samples on ice and one laboratory reported thawing on dry ice. About half of the laboratories spun the samples down before processing. The majority of laboratories (N = 6) used the MO-BIO PowerSoil kit for DNA extraction and one used the MO-BIO PowerMag kit. One laboratory used two methods (MO-BIO PowerSoil and Qiagen QIAamp) and one laboratory used an in-house protocol. One laboratory each used Qiagen QIAsymphony, Zymo fecal DNA miniprep, Promega Maxwell, Omega BioTek EZ-96, Chemagen Chemagic, and GeneRite DNA-EZ RW02 for DNA extraction. The majority of the laboratories used a homogenizer including MO-BIO, MP Bio, Qiagen, Scientific Industries, BioSpec, and Chemagen. See Supplementary Data sets 2 and 4 for per-laboratory protocol details.
shorter than 70 nt were discarded. Human genome assembly version hg38 was downloaded from https://genome.ucsc.edu/ and used as reference for removal of human 'contaminant' sequences from sequence data. Taxonomic profiles of filtered shotgun sequence data sets were determined with MetaPhlAn2 (ref. 22) (http://huttenhower.sph.harvard.edu/metaphlan2).
Data Integration. OTU tables were redeposited at the DCC by all bioinformatics laboratories and made available for integrative analysis by the consortium. Raw sequences are available at BioProject SRP047083 and processed data products at http://mbqc.org. Integrative analyses that relied on OTU matching were performed either using only the subset of OTUs assigned to Greengenes identifiers (although open reference OTUs are available on the DCC) or, for taxonomic analyses, using the lowest non-OTU level taxonomic assignment (species, genus, or otherwise). The taxonomic features and diversity measures used for each analysis are noted on the relevant figures and tables.
Ecological diversity measures and univariate effect modeling. In most cases, Bray-Curtis dissimilarity was used for beta-diversity analyses and inverse Simpson for alpha-diversity. This includes the main univariate assessment of biological and technical effect sizes (Fig. 3) , in which four tests were performed: 1) beta-diversity comparisons of replicate samples (i.e., samples from identical specimens) within each laboratory, without varying any parameters, to identify which laboratories were most internally consistent (Fig. 3a,b) ; 2) beta-diversity comparisons of replicate samples between laboratories, varying only the bioinformatics (Fig. 3a) or handling laboratory, to identify which laboratories agreed with each specimen type's consensus readout (Fig. 3b); 3) alpha-diversity of all stratified samples within laboratory, to identify which performed more complete extractions (inducing higher diversity) or inflated positive-control diversity (inducing lower diversity); and 4) beta-diversity across all samples, varying only one parameter at a time (bioinformatics laboratory, extracter, sequencer, or specimen, Fig. 3c ). This identified, on average, the degree of change induced in microbial community readout when considering each variable in isolation.
Multivariate effect modeling. We fit two linear mixed models to identify protocol variables significantly associated with magnitude (fixed effects) or variability (random effects) in microbiome measures. We first fit a full model with fixed effects for pre-extraction, collapsed specimen type, collapsed health status, PCR primer, read length, collapsed sequencing chemistry version, PhiX fraction, fraction quality bases, log read count, collapsed OTU software, OTU clustering, taxonomic assignment method, and OTU filtering; and random effects for specimen number, handling laboratory, and bioinformatics laboratory. We also fit a simplified model with fixed effects for handling laboratory, bioinformatics laboratory, and pre-extraction; and a random effect for specimen number. The simple model used handling laboratory HL-J and bioinformatics laboratory BL-9B for the reference categories. Arcsine-square root transformed abundances (for variance stabilization) were used as outcomes, from the four phyla present in at least half of all subjects (Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria). We fit each model using restricted maximum likelihood (REML) estimation in the lme4 R package (version 1.1.11). P-values for fixed and random effects were calculated using a likelihood-ratio test and adjusted using the Benjamini-Hochberg-Yekutieli method across all four phyla per model. Data Availability. Raw sequences are available at BioProject SRP047083 and processed data products, copies of supplementary materials, and computational workflows are available at http://mbqc.org.
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
All software used for individual labs' bioinformatic protocols and for integrative analyses is provided at the DCC, http://mbqc.org (under Baseline Data).
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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